START South Texas Accelerated Research Therapeutics — San Antonio, Texas

Public research footprint of START South Texas Accelerated Research Therapeutics, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Advanced Solid Tumor · Solid Tumors · Non-Small Cell Lung Cancer · Breast Cancer

Recently updated registry entries

NCT05267626 — Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in… (Recruiting)
NCT05846516 — A Study to Evaluate ATP150/ATP152/ATP162, VSV-GP154 and Ezabenlimab in Patients With… (Active Not Recruiting)
NCT07300150 — A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at START South Texas Accelerated Research Therapeutics?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.